Shares of Autolus Therapeutics plc (NASDAQ:AUTL – Get Free Report) reached a new 52-week high during trading on Thursday after The Goldman Sachs Group raised their price target on the stock from $3.20 to $4.80. The Goldman Sachs Group currently has a neutral rating on the stock. Autolus Therapeutics traded as high as $5.00 and […]